<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tassano E</submitter><funding>Austrian Science Fund FWF</funding><pagination>2742-2751</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6099231</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>360(14)</volume><pubmed_abstract>The biocatalytic asymmetric disproportionation of aldehydes catalyzed by horse liver alcohol dehydrogenase (HLADH) was assessed in detail on a series of racemic 2-arylpropanals. Statistical optimization by means of design of experiments (DoE) allowed the identification of critical interdependencies between several reaction parameters and revealed a specific experimental window for reaching an 'optimal compromise' in the reaction outcome. The biocatalytic system could be applied to a variety of 2-arylpropanals and granted access in a redox-neutral manner to enantioenriched (&lt;i>S&lt;/i>)-profens and profenols following a parallel interconnected dynamic asymmetric transformation (PIDAT). The reaction can be performed in aqueous buffer at ambient conditions, does not rely on a sacrificial co-substrate, and requires only catalytic amounts of cofactor and a single enzyme. The high atom-efficiency was exemplified by the conversion of 75 mM of &lt;i>rac&lt;/i>-2-phenylpropanal with 0.03 mol% of HLADH in the presence of ∼0.013 eq. of oxidized nicotinamide adenine dinucleotide (NAD&lt;sup>+&lt;/sup>), yielding 28.1 mM of (&lt;i>S&lt;/i>)-2-phenylpropanol in 96% &lt;i>ee&lt;/i> and 26.5 mM of (&lt;i>S&lt;/i>)-2-phenylpropionic acid in 89% &lt;i>ee&lt;/i>, in 73% overall conversion. Isolated yield of 62% was obtained on 100 mg-scale, with intact enantiopurities.</pubmed_abstract><journal>Advanced synthesis &amp; catalysis</journal><pubmed_title>Biocatalytic Parallel Interconnected Dynamic Asymmetric Disproportionation of α-Substituted Aldehydes: Atom-Efficient Access to Enantiopure (&lt;i>S&lt;/i>)-Profens and Profenols.</pubmed_title><pmcid>PMC6099231</pmcid><funding_grant_id>P 30519</funding_grant_id><funding_grant_id>P30519</funding_grant_id><pubmed_authors>Tassano E</pubmed_authors><pubmed_authors>Hall M</pubmed_authors><pubmed_authors>Faber K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Biocatalytic Parallel Interconnected Dynamic Asymmetric Disproportionation of α-Substituted Aldehydes: Atom-Efficient Access to Enantiopure (&lt;i>S&lt;/i>)-Profens and Profenols.</name><description>The biocatalytic asymmetric disproportionation of aldehydes catalyzed by horse liver alcohol dehydrogenase (HLADH) was assessed in detail on a series of racemic 2-arylpropanals. Statistical optimization by means of design of experiments (DoE) allowed the identification of critical interdependencies between several reaction parameters and revealed a specific experimental window for reaching an 'optimal compromise' in the reaction outcome. The biocatalytic system could be applied to a variety of 2-arylpropanals and granted access in a redox-neutral manner to enantioenriched (&lt;i>S&lt;/i>)-profens and profenols following a parallel interconnected dynamic asymmetric transformation (PIDAT). The reaction can be performed in aqueous buffer at ambient conditions, does not rely on a sacrificial co-substrate, and requires only catalytic amounts of cofactor and a single enzyme. The high atom-efficiency was exemplified by the conversion of 75 mM of &lt;i>rac&lt;/i>-2-phenylpropanal with 0.03 mol% of HLADH in the presence of ∼0.013 eq. of oxidized nicotinamide adenine dinucleotide (NAD&lt;sup>+&lt;/sup>), yielding 28.1 mM of (&lt;i>S&lt;/i>)-2-phenylpropanol in 96% &lt;i>ee&lt;/i> and 26.5 mM of (&lt;i>S&lt;/i>)-2-phenylpropionic acid in 89% &lt;i>ee&lt;/i>, in 73% overall conversion. Isolated yield of 62% was obtained on 100 mg-scale, with intact enantiopurities.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Jul</publication><modification>2025-04-19T06:29:48.013Z</modification><creation>2019-03-26T23:52:48Z</creation></dates><accession>S-EPMC6099231</accession><cross_references><pubmed>30147639</pubmed><doi>10.1002/adsc.201800541</doi></cross_references></HashMap>